4J94-093, viroseq HIV-1 GT V2 genotype s

Ended Awarded

Contract number
W81XWH21F0323
Awardee
Awarding agency
Obligated
$155,596

Award facts

Contract value 100% obligated
$155,596.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rosemont, IL 60018, USA

Award details come from SAM.gov/FPDS.

About this award

The Department of the Army Medical Command awarded Abbott Molecular Inc., a subsidiary of Abbott Laboratories, a $155,596 firm fixed price call against the ViroSeq HIV-1 GT V2 Genotype blanket purchase agreement to deliver genotyping services. Under this contract, Abbott Molecular will provide the Army with genotyping of HIV-1 samples to determine viral genotype for antiretroviral drug resistance interpretation. Performance will take place in Des Plaines, Illinois. No set aside designation was applied to this award to support the Army Medical Command's efforts to monitor and manage HIV drug resistance among those in its healthcare system.

Quick answers

Who was awarded contract W81XWH21F0323?

W81XWH21F0323 was awarded to Abbott Molecular Inc. by Medical Command (Department of the Army) on August 19, 2021.

How much is contract W81XWH21F0323 worth?

The government has obligated $155,596 on W81XWH21F0323.

Is contract W81XWH21F0323 an order under another contract?

Yes. W81XWH21F0323 is a BPA call under W81XWH19A0009, a blanket purchase agreement.

Was contract W81XWH21F0323 competed?

The extent of competition for W81XWH21F0323 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award